These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1876130)

  • 41. Response to "transferring methadone-stabilized pregnant patients to buprenorphine".
    Newman RG
    Am J Addict; 2006; 15(5):400; author reply 401-2. PubMed ID: 16966198
    [No Abstract]   [Full Text] [Related]  

  • 42. A meta-analysis comparing the effectiveness of buprenorphine and methadone.
    West SL; O'Neal KK; Graham CW
    J Subst Abuse; 2000; 12(4):405-14. PubMed ID: 11452842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Background and design of a controlled clinical trial (ARC 090) for the treatment of opioid dependence.
    Johnson RE; Fudala PJ
    NIDA Res Monogr; 1992; 128():14-24. PubMed ID: 1436012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study.
    Soyka M; Träder A; Klotsche J; Backmund M; Bühringer G; Rehm J; Wittchen HU
    J Clin Psychopharmacol; 2011 Oct; 31(5):678-80. PubMed ID: 21881461
    [No Abstract]   [Full Text] [Related]  

  • 45. Two new rating scales for opiate withdrawal.
    Handelsman L; Cochrane KJ; Aronson MJ; Ness R; Rubinstein KJ; Kanof PD
    Am J Drug Alcohol Abuse; 1987; 13(3):293-308. PubMed ID: 3687892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Were the changes to Sweden's maintenance treatment policy 2000-06 related to changes in opiate-related mortality and morbidity?
    Romelsjö A; Engdahl B; Stenbacka M; Fugelstad A; Davstad I; Leifman A; Thiblin I
    Addiction; 2010 Sep; 105(9):1625-32. PubMed ID: 20626377
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.
    San L; Camí J; Fernández T; Ollé JM; Peri JM; Torrens M
    Br J Addict; 1992 Jan; 87(1):55-62. PubMed ID: 1311974
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treating opiate addiction, Part I. Detoxification and maintenance.
    Harv Ment Health Lett; 2004 Dec; 21(6):4-6. PubMed ID: 15717347
    [No Abstract]   [Full Text] [Related]  

  • 49. Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.
    Stine SM; Kosten TR
    Am J Drug Alcohol Abuse; 1994 Nov; 20(4):445-58. PubMed ID: 7832179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
    Janiri L; Mannelli P; Persico AM; Serretti A; Tempesta E
    Drug Alcohol Depend; 1994 Oct; 36(2):139-45. PubMed ID: 7851281
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.
    Magura S; Lee JD; Hershberger J; Joseph H; Marsch L; Shropshire C; Rosenblum A
    Drug Alcohol Depend; 2009 Jan; 99(1-3):222-30. PubMed ID: 18930603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metyrapone-induced withdrawal symptoms: symptoms in methadone-maintained patients.
    Kennedy JA; Hartman N; Sbriglio R; Khuri E; Albeck H; Kreek MJ
    NIDA Res Monogr; 1990; 105():416. PubMed ID: 1876057
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of ethnicity on low-dose opiate stabilization.
    Kosten TR; Rayford BS
    J Subst Abuse Treat; 1995; 12(2):111-6. PubMed ID: 7623388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Actigraphic measurements in opioid detoxification with methadone or buprenorphine.
    Pjrek E; Frey R; Naderi-Heiden A; Strnad A; Kowarik A; Kasper S; Winkler D
    J Clin Psychopharmacol; 2012 Feb; 32(1):75-82. PubMed ID: 22198453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
    Ahmadi J; Razeghian Jahromi L
    Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and diagnostic reliability of methadone maintenance detoxification fear.
    Milby JB; Gurwitch RH; Wiebe DJ; Ling W; McLellan AT; Woody GE
    Am J Psychiatry; 1986 Jun; 143(6):739-43. PubMed ID: 3717396
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of buprenorphine in methadone-dependent volunteers.
    Strain EC; Bigelow GE; Preston KL; Liebson I
    NIDA Res Monogr; 1990; 105():584. PubMed ID: 1715035
    [No Abstract]   [Full Text] [Related]  

  • 58. Rapid detoxification from opioid dependence.
    Kosten TR; Krystal JH; Charney DS; Price LH; Morgan CH; Kleber HD
    Am J Psychiatry; 1989 Oct; 146(10):1349. PubMed ID: 2675644
    [No Abstract]   [Full Text] [Related]  

  • 59. Why do patients report transferring between methadone and buprenorphine?
    Winstock AR; Lintzeris N; Lea T
    Drug Alcohol Rev; 2009 Nov; 28(6):686-7. PubMed ID: 19930026
    [No Abstract]   [Full Text] [Related]  

  • 60. Cardiovascular-associated disease in an addicted population: an observation study.
    Demarie D; Marletta G; Imazio M; Cappa C; Ferro S; Compostino R; De Vivo E; Trinchero R; Bignamini E
    J Cardiovasc Med (Hagerstown); 2011 Jan; 12(1):51-4. PubMed ID: 21135593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.